Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis

AIM: We investigated the chemotherapy effect of resectable colorectal cancer with liver metastasis (CRLM) on the function of intrahepatic immune cells. METHODS: We classified patients into adjuvant chemotherapy (bevacizumab+CapeOX) after hepatectomy group (group A) and neoadjuvant chemotherapy follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, Fumihiro, Ishiyama, Kohei, Tanaka, Yuka, Kobayashi, Tsuyoshi, Hashimoto, Masakazu, Saeki, Yoshihiro, Ishida, Nobuki, Taguchi, Kazuhiro, Tanaka, Junko, Arihiro, Koji, Ohdan, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139723/
https://www.ncbi.nlm.nih.gov/pubmed/30238080
http://dx.doi.org/10.1002/ags3.12195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139723/
https://www.ncbi.nlm.nih.gov/pubmed/30238080
http://dx.doi.org/10.1002/ags3.12195

Ejemplares similares